HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Treatment of no. II type essential hyperlipoproteinemia with a new therapeutic agent, celluline].

AuthorsC Thiffault, M Bélanger, M Pouliot
JournalCanadian Medical Association journal (Can Med Assoc J) Vol. 103 Issue 2 Pg. 165-6 (Jul 18 1970) ISSN: 0008-4409 [Print] CANADA
Vernacular TitleTraitement de l'hyperlipoproténémie essentielle de type II par un nouvel agent thérapeutique, la celluline.
PMID5430055 (Publication Type: Journal Article)
Chemical References
  • Lipoproteins
  • Methylcellulose
Topics
  • Adult
  • Humans
  • Hyperlipidemias (drug therapy)
  • Lipoproteins (blood)
  • Methylcellulose (administration & dosage, therapeutic use)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: